NVCR Q3 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$92M+42.2% YoY

Gross Profit

$69M75.1% margin

Operating Income

$4M4.2% margin

Net Income

$2M2.1% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$12M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$444M

Total Liabilities

$253M

Stockholders' Equity

$190M

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$65M	+42.2%
Gross Profit	$69M	$46M	+51.0%
Operating Income	$4M	-$5M	+173.5%
Net Income	$2M	-$12M	+116.5%

Geographic Segments

UNITED STATES

$61M54%

EMEA

$24M22%

GERMANY

$22M19%

JAPAN

$5M4%

CHINA

$1M1%